「borderline」の検索結果

This skill recommends against initiating treatments aimed at normalizing cortisol or its action when only borderline biochemical abnormalities of the hypothalamic-pituitary-adrenal (HPA) axis are present without specific signs of Cushing's syndrome. Use when encountering borderline urinary free cortisol, late-night salivary cortisol, or dexamethasone suppression test results without classic Cushingoid features; triggers include borderline UFC (1-2× ULN), equivocal late-night salivary cortisol, or nondiagnostic low-dose DST.

日本語の概要は準備中です。原文の説明を表示しています。

This skill recommends against initiating cortisol-lowering treatment when there is no established diagnosis of Cushing's syndrome. It is triggered when a clinician considers treating suspected CS based only on borderline biochemical abnormalities or nonspecific signs without confirmatory testing; examples include "suspected CS", "borderline UFC", "no confirmed diagnosis", "consider empiric ketoconazole".

日本語の概要は準備中です。原文の説明を表示しています。

Work a primary-prevention patient through the 2026 ACC/AHA multisociety dyslipidaemia guideline CPR framework — Calculate (10-year and 30-year PREVENT-ASCVD), Classify (low / borderline / intermediate / high), Personalize (demographic, clinical, biomarker, and reproductive risk enhancers), and Reclassify (coronary artery calcium scoring where appropriate). Use when a clinician asks how to assess ASCVD risk for primary prevention, who needs a statin, borderline risk patient what to do, intermediate risk should I start a statin, risk enhancers to look for, premature family history of ASCVD how does it change risk, pregnancy-related risk factors, PCOS and cardiovascular risk. Grounded in the 2026 ACC/AHA multisociety dyslipidaemia guideline.

日本語の概要は準備中です。原文の説明を表示しています。

Psychoeducation on depression, anxiety disorders, PTSD, bipolar disorder, schizophrenia, ADHD, and borderline personality disorder. Knowledge sharing without diagnosis.

日本語の概要は準備中です。原文の説明を表示しています。

Psychoedukation zu Depression, Angststörungen, PTBS, bipolarer Störung, Schizophrenie, ADHS und Borderline. Wissensvermittlung ohne Diagnose.

日本語の概要は準備中です。原文の説明を表示しています。

Classifies personal vs non-personal data per GDPR Art. 4(1) definition test with decision tree for borderline cases. References Breyer v Germany CJEU C-582/14 dynamic IP ruling and WP29 Opinion 4/2007. Keywords: personal data, GDPR Art 4, data classification, Breyer ruling, identifiability test, PII.

日本語の概要は準備中です。原文の説明を表示しています。

Use when a task needs the judgment of a tenure-track/tenured Education Professor in a teacher-preparation program — designing a licensure course unit against InTASC/CAEP standards, deciding whether a candidate's borderline edTPA score needs a targeted or full retake, triaging a failing student-teaching placement, or assembling CAEP self-study evidence for reaccreditation.

日本語の概要は準備中です。原文の説明を表示しています。

Use when a task needs the judgment of a Construction and Building Inspector — deciding whether a phase of work passes a hold-point inspection (foundation, framing, rough-in, insulation, final) or gets red-tagged, writing a correction notice that will hold up on appeal, resolving a conflict between the approved plans and field conditions, applying a specific IRC/IBC section to a borderline condition (egress, smoke/CO detector placement, GFCI/AFCI locations), or deciding whether schedule pressure from a contractor changes the call.

日本語の概要は準備中です。原文の説明を表示しています。

Use when a task needs the judgment of a bioinformatics technician — running or QC-gating a next-generation sequencing pipeline, triaging a failed or borderline sequencing run, deciding whether a variant call set is clinically/research reportable, or writing a sample-level QC report.

日本語の概要は準備中です。原文の説明を表示しています。

Determines if PAC/PRA ratio and PAC levels indicate positive or provisionally positive screening for primary aldosteronism. Triggered when a clinician has PAC and PRA results and asks “Is this screening test positive for PA?” or needs to interpret borderline results.

日本語の概要は準備中です。原文の説明を表示しています。

Decide whether a kidney from a brain-dead deceased donor (DBD) with diabetes mellitus and/or hypertension is suitable for transplantation, using the ISOT 2025 Delphi consensus and Table 4 eligibility checklist. Trigger when a clinician asks "can I use a kidney from a diabetic deceased donor", "is this DBD with HTN/DM acceptable", "ECD donor with diabetes — accept or decline", "DBD eligibility for hypertensive donor", or shares a deceased donor with diabetes or hypertension and needs an accept/borderline/decline decision.

日本語の概要は準備中です。原文の説明を表示しています。

Decide when to order coronary artery calcium (CAC) scoring in a primary-prevention patient and interpret the result per the 2026 ACC/AHA multisociety dyslipidaemia guideline. Covers the Class 1 indication (men ≥40 / women ≥45, borderline / intermediate PREVENT-ASCVD risk, uncertainty about LLT), CAC score interpretation (0, 1–99, 100–299, ≥300, ≥1000), how CAC modifies LDL and non-HDL goals, when to repeat CAC, and pitfalls (incidental CAC on non-cardiac CT, radiation, cost). Use when a clinician asks should I order a CAC score, CAC indications, what does CAC 150 mean, treatment goals with CAC score, repeat CAC frequency, CAC in a smoker, CAC vs CCTA, is CAC useful in intermediate risk. Grounded in the 2026 ACC/AHA multisociety dyslipidaemia guideline.

日本語の概要は準備中です。原文の説明を表示しています。

Set absolute LDL-C, non-HDL-C, and ApoB treatment goals, PLUS percent LDL-C reduction, for a primary-prevention patient on lipid-lowering therapy per the re-introduced treatment goals in the 2026 ACC/AHA multisociety dyslipidaemia guideline. Covers goals by PREVENT-ASCVD category (low / borderline / intermediate / high), by CAC score, in severe hypercholesterolaemia / FH, in diabetes with multiple ASCVD risk factors, and the ApoB targets once LDL-C and non-HDL-C goals are met. Use when a clinician asks what LDL goal to aim for, LDL target for intermediate risk, non-HDL goal, ApoB target, dual goals on statin, patient at goal or not, how low should LDL go, statin not enough what next. Grounded in the 2026 ACC/AHA multisociety dyslipidaemia guideline.

日本語の概要は準備中です。原文の説明を表示しています。

Calculate and interpret the PREVENT-ASCVD risk score (10-year and 30-year) for primary prevention of atherosclerotic cardiovascular disease per the 2026 ACC/AHA multisociety dyslipidaemia guideline. Covers inputs required, risk-category thresholds (low <3%, borderline 3–<5%, intermediate 5–<10%, high ≥10%), when to use the 30-year calculation (adults 30–59), and how PREVENT differs from the older Pooled Cohort Equations (lower risk estimates by 40–50%, race-agnostic). Use when a clinician asks what the 10-year ASCVD risk is, how to calculate PREVENT, PCE vs PREVENT, risk category for this patient, does my patient need a statin, 30-year risk calculation, primary prevention risk assessment. Grounded in the 2026 ACC/AHA multisociety dyslipidaemia guideline.

日本語の概要は準備中です。原文の説明を表示しています。

关于抑郁症、焦虑障碍、创伤后应激障碍（PTSD）、双相情感障碍、精神分裂症、注意缺陷多动障碍（ADHD）和边缘性人格障碍的心理教育。提供知识讲解，不进行临床诊断。

日本語の概要は準備中です。原文の説明を表示しています。

Психообразование по вопросам депрессии, тревожных расстройств, ПТСР, биполярного расстройства, шизофрении, СДВГ и пограничного расстройства личности. Предоставление информации без постановки диагноза.

日本語の概要は準備中です。原文の説明を表示しています。

うつ病、不安症群、PTSD、双極性障害、統合失調症、ADHD、境界性パーソナリティ障害に関する心理教育。診断を行わない知識共有。

Psicoeducación sobre depresión, trastornos de ansiedad, TEPT, trastorno bipolar, esquizofrenia, TDAH y trastorno límite de la personalidad. Transmisión de conocimientos sin diagnóstico.

日本語の概要は準備中です。原文の説明を表示しています。

Auto-review pipeline — reads the full CEO, design, eng, and DX review skills from disk and runs them sequentially with auto-decisions using 6 decision principles. Surfaces taste decisions (close approaches, borderline scope, codex disagreements) at a final approval gate. One command, fully reviewed plan out. Use when asked to "auto review", "autoplan", "run all reviews", "review this plan automatically", or "make the decisions for me". Proactively suggest when the user has a plan file and wants to run the full review gauntlet without answering 15-30 intermediate questions. (gstack) Voice triggers (speech-to-text aliases): "auto plan", "automatic review".

日本語の概要は準備中です。原文の説明を表示しています。